It Looks Like Rekah Pharmaceutical Industry Ltd.'s (TLV:REKA) CEO May Expect Their Salary To Be Put Under The Microscope
Aug 01
Have your own idea? Try our Stock Screener
Israeli (TA) Pharma Industry Analysis
UpdatedAug 12, 2025
DataAggregated Company Financials
Companies8
- 7D4.4%
- 3M-0.3%
- 1Y-22.9%
- YTD-13.5%
The Pharma industry is up 4.4% in the last week, with InterCure up 12%. In the same time, Y.B Urban Renewal - Residential Development was down 5.3%. In the past year, the industry is down 23%.
Industry Valuation and Performance
Has the Israeli Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 12 Aug 2025 | ₪579.3m | ₪716.7m | -₪67,297,826.10 | 29.2x | -8.6x | 0.8x |
| Thu, 10 Jul 2025 | ₪581.5m | ₪716.7m | -₪71,424,844.20 | 31.1x | -8.1x | 0.8x |
| Sat, 07 Jun 2025 | ₪569.7m | ₪716.7m | -₪72,130,458.70 | 31.4x | -7.9x | 0.8x |
| Mon, 05 May 2025 | ₪595.7m | ₪732.8m | -₪82,251,480.00 | 14.8x | -7.2x | 0.8x |
| Wed, 02 Apr 2025 | ₪592.2m | ₪832.5m | -₪145,999,388.00 | 11.9x | -4.1x | 0.7x |
| Fri, 28 Feb 2025 | ₪655.9m | ₪828.6m | -₪180,217,034.00 | 21.7x | -3.6x | 0.8x |
| Sun, 26 Jan 2025 | ₪681.1m | ₪828.6m | -₪180,346,437.80 | 20.7x | -3.8x | 0.8x |
| Tue, 24 Dec 2024 | ₪677.9m | ₪828.6m | -₪181,385,165.60 | 19.6x | -3.7x | 0.8x |
| Thu, 21 Nov 2024 | ₪606.7m | ₪816.0m | -₪184,439,904.40 | 24x | -3.3x | 0.7x |
| Sat, 19 Oct 2024 | ₪635.9m | ₪808.7m | -₪205,170,871.90 | 23.2x | -3.1x | 0.8x |
| Mon, 16 Sep 2024 | ₪702.7m | ₪810.4m | -₪243,856,180.50 | 23.9x | -2.9x | 0.9x |
| Wed, 14 Aug 2024 | ₪624.1m | ₪901.7m | -₪263,237,842.80 | n/a | -2.4x | 0.7x |
| Fri, 12 Jul 2024 | ₪727.7m | ₪901.7m | -₪261,295,768.80 | n/a | -2.8x | 0.8x |
| Sun, 09 Jun 2024 | ₪710.5m | ₪891.0m | -₪258,882,999.60 | n/a | -2.7x | 0.8x |
| Tue, 07 May 2024 | ₪876.5m | ₪886.2m | -₪260,921,816.00 | n/a | -3.4x | 1x |
| Thu, 04 Apr 2024 | ₪779.8m | ₪948.8m | -₪175,523,640.00 | 21.3x | -4.4x | 0.8x |
| Sat, 02 Mar 2024 | ₪669.0m | ₪972.3m | -₪210,497,898.10 | 15.7x | -3.2x | 0.7x |
| Mon, 29 Jan 2024 | ₪539.0m | ₪972.3m | -₪213,309,809.00 | 10.2x | -2.5x | 0.6x |
| Wed, 27 Dec 2023 | ₪571.7m | ₪972.3m | -₪211,841,718.00 | 10.1x | -2.7x | 0.6x |
| Fri, 24 Nov 2023 | ₪566.6m | ₪958.8m | -₪209,196,254.00 | 9.3x | -2.7x | 0.6x |
| Sun, 22 Oct 2023 | ₪628.5m | ₪958.8m | -₪214,924,443.00 | 10.6x | -2.9x | 0.7x |
| Tue, 19 Sep 2023 | ₪694.2m | ₪958.8m | -₪209,955,650.00 | 14x | -3.3x | 0.7x |
| Thu, 17 Aug 2023 | ₪648.9m | ₪918.8m | -₪127,455,177.00 | 8.3x | -5.1x | 0.7x |
| Sat, 15 Jul 2023 | ₪672.6m | ₪918.8m | -₪124,687,171.00 | 8.8x | -5.4x | 0.7x |
| Mon, 12 Jun 2023 | ₪778.6m | ₪912.7m | -₪124,766,918.00 | 11x | -6.2x | 0.9x |
| Wed, 10 May 2023 | ₪834.2m | ₪887.2m | -₪122,177,558.00 | 8.6x | -6.8x | 0.9x |
| Fri, 07 Apr 2023 | ₪844.8m | ₪829.2m | -₪98,399,832.00 | 11.8x | -8.6x | 1x |
| Sun, 05 Mar 2023 | ₪892.2m | ₪815.6m | -₪72,001,205.00 | 13.8x | -12.4x | 1.1x |
| Tue, 31 Jan 2023 | ₪1.0b | ₪739.7m | -₪56,381,825.00 | 17x | -17.8x | 1.4x |
| Thu, 29 Dec 2022 | ₪969.9m | ₪739.7m | -₪58,052,575.00 | 16.9x | -16.7x | 1.3x |
| Sat, 26 Nov 2022 | ₪1.2b | ₪728.3m | -₪55,840,113.00 | 23.3x | -22.4x | 1.7x |
| Mon, 24 Oct 2022 | ₪1.3b | ₪689.4m | -₪60,910,166.00 | 31.7x | -21.5x | 1.9x |
| Wed, 21 Sep 2022 | ₪1.3b | ₪705.7m | -₪84,163,902.00 | 30.5x | -15.8x | 1.9x |
| Fri, 19 Aug 2022 | ₪1.6b | ₪781.4m | -₪105,565,244.00 | 35.3x | -15x | 2x |
Price to Earnings Ratio
-15x
Current Industry PE
- Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading close to its 3-year average PS ratio of 0.93x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 2.8% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | -2.40% | |
| Healthcare | -0.40% | |
| Pharma | 4.44% | |
| Pharma | 4.44% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| INCR InterCure | ₪5.89 | 16.7% +₪39.9m | -20.0% | PS1.2x | |
| SEMG Seach Medical Group | ₪2.79 | 2.1% +₪1.9m | 82.7% | PE6.2x | |
| YBRD Y.B Urban Renewal - Residential Development | ₪7.33 | 4.0% +₪1.1m | -60.0% | PS52.6x | |
| REKA Rekah Pharmaceutical Industry | ₪11.94 | 0.6% +₪799.0k | -12.5% | PE52.5x | |
| TKUN Tikun Olam-Cannbit Pharmaceuticals | ₪0.37 | 2.2% +₪679.7k | 16.9% | PS0.9x |